These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12374286)

  • 1. Cell volume and ion changes during apoptotic cell death.
    Gómez-Angelats M; Cidlowski JA
    Adv Cancer Res; 2002; 85():175-201. PubMed ID: 12374286
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell death in T- and B-cell development.
    Debatin KM
    Ann Hematol; 2001; 80 Suppl 3():B29-31. PubMed ID: 11757701
    [No Abstract]   [Full Text] [Related]  

  • 3. Apoptosis by death factor.
    Nagata S
    Cell; 1997 Feb; 88(3):355-65. PubMed ID: 9039262
    [No Abstract]   [Full Text] [Related]  

  • 4. Apoptosis control by death and decoy receptors.
    Ashkenazi A; Dixit VM
    Curr Opin Cell Biol; 1999 Apr; 11(2):255-60. PubMed ID: 10209153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell volume in cell proliferation and apoptotic cell death.
    Lang F; Lepple-Wienhues A; Szabó I; Siemen D; Gulbins E
    Contrib Nephrol; 1998; 123():158-68. PubMed ID: 9761967
    [No Abstract]   [Full Text] [Related]  

  • 6. The kiss of death: promises and failures of death receptors and ligands in cancer therapy.
    Daniel PT; Wieder T; Sturm I; Schulze-Osthoff K
    Leukemia; 2001 Jul; 15(7):1022-32. PubMed ID: 11455969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis and NF-kappa B: the FADD connection.
    Duckett CS
    J Clin Invest; 2002 Mar; 109(5):579-80. PubMed ID: 11877464
    [No Abstract]   [Full Text] [Related]  

  • 8. Death-receptor contribution to the germinal-center reaction.
    van Eijk M; Defrance T; Hennino A; de Groot C
    Trends Immunol; 2001 Dec; 22(12):677-82. PubMed ID: 11738998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caspase-induced inactivation of the anti-apoptotic TRAF1 during Fas ligand-mediated apoptosis.
    Irmler M; Steiner V; Ruegg C; Wajant H; Tschopp J
    FEBS Lett; 2000 Feb; 468(2-3):129-33. PubMed ID: 10692572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8.
    Sprick MR; Rieser E; Stahl H; Grosse-Wilde A; Weigand MA; Walczak H
    EMBO J; 2002 Sep; 21(17):4520-30. PubMed ID: 12198154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of Fas ligand-induced apoptosis by TNF.
    Elzey BD; Griffith TS; Herndon JM; Barreiro R; Tschopp J; Ferguson TA
    J Immunol; 2001 Sep; 167(6):3049-56. PubMed ID: 11544288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the Fas/Fas ligand death receptor pathway in ginseng saponin metabolite-induced apoptosis in HepG2 cells.
    Oh SH; Yin HQ; Lee BH
    Arch Pharm Res; 2004 Apr; 27(4):402-6. PubMed ID: 15180305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of fas death signals by FLIPs.
    Tschopp J; Irmler M; Thome M
    Curr Opin Immunol; 1998 Oct; 10(5):552-8. PubMed ID: 9794838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caspase-3 is a component of Fas death-inducing signaling complex in lipid rafts and its activity is required for complete caspase-8 activation during Fas-mediated cell death.
    Aouad SM; Cohen LY; Sharif-Askari E; Haddad EK; Alam A; Sekaly RP
    J Immunol; 2004 Feb; 172(4):2316-23. PubMed ID: 14764700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fas ligand-induced c-Jun kinase activation in lymphoid cells requires extensive receptor aggregation but is independent of DAXX, and Fas-mediated cell death does not involve DAXX, RIP, or RAIDD.
    Villunger A; Huang DC; Holler N; Tschopp J; Strasser A
    J Immunol; 2000 Aug; 165(3):1337-43. PubMed ID: 10903735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in apoptosis genes: a pathogenetic factor for human disease.
    Müllauer L; Gruber P; Sebinger D; Buch J; Wohlfart S; Chott A
    Mutat Res; 2001 Jul; 488(3):211-31. PubMed ID: 11397650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against Fas-mediated and tumor necrosis factor receptor 1-mediated liver injury by blockade of FADD without loss of nuclear factor-kappaB activation.
    Seino K; Setoguchi Y; Ogino T; Kayagaki N; Akiba H; Nakano H; Taniguchi H; Takada Y; Yuzawa K; Todoroki T; Fukuchi Y; Yagita H; Okumura K; Fukao K
    Ann Surg; 2001 Nov; 234(5):681-8. PubMed ID: 11685033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
    Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fas and Fas ligand in gut and liver.
    Pinkoski MJ; Brunner T; Green DR; Lin T
    Am J Physiol Gastrointest Liver Physiol; 2000 Mar; 278(3):G354-66. PubMed ID: 10712254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fas/FasL signaling allows extracelluar-signal regulated kinase to regulate cytochrome c release in oridonin-induced apoptotic U937 cells.
    Liu YQ; Mu ZQ; You S; Tashiro S; Onodera S; Ikejima T
    Biol Pharm Bull; 2006 Sep; 29(9):1873-9. PubMed ID: 16946501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.